Cite
HARVARD Citation
Virk, H. et al. (2022). Imatinib responsive erythrocytosis in a patient with FIP1L1::PDGFRA rearranged myeloid neoplasm with hypereosinophilia – Another manifestation of a stem cell neoplasm. Leukemia research. p. . [Online].